Association between IL28B polymorphisms and first-phase viral load decrease in chronic hepatitis C virus-infected patients treated with peginterferon alfa-2b/ribavirin. [electronic resource]
Producer: 20120301Description: 538-9 p. digitalISSN:- 1872-7913
- Antiviral Agents -- therapeutic use
- Hepacivirus -- drug effects
- Hepatitis C, Chronic -- drug therapy
- Humans
- Interferon alpha-2
- Interferon-alpha -- therapeutic use
- Interferons
- Interleukins -- genetics
- Polyethylene Glycols -- therapeutic use
- Polymorphism, Single Nucleotide -- genetics
- Recombinant Proteins -- therapeutic use
- Ribavirin -- therapeutic use
- Treatment Outcome
- Viral Load -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.